Mortality after 16 years for participants randomized to the multiple risk factor intervention trial

Circulation

Volumn 94, Issue 5, 1996, Pages 946-951

  Kjelsberg, Marcus O ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

blood pressure; coronary disease; mortality; trials

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

EID: 0029813486     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.5.946     Document Type: Article

References (30)

1. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA. 1982;248:1465-1477.
2. Multiple Risk Factor Intervention Trial Research Group. Coronary heart disease, nonfatal myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Am J Cardiol. 1986;58:1-13.
3. Multiple Risk Factor Intervention Trial Research Group. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial: findings related to a priori hypotheses of the trial, JAMA. 1990;263:1795-1801.
4. Multiple Risk Factor Intervention Trial Research Group. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. Circulation. 1990;82:1616-1628.
5. Multiple Risk Factor Intervention Trial Research Group. Statistical design considerations in the NHLI Multiple Risk Factor Intervention Trial. J Chronic Dis. 1977;30:261-275.
6. Sherwin R, Kaelber CT, Kezdi P, Kjelsberg MO, Thomas HE Jr. The Multiple Risk Factor Intervention Trial (MRFIT), II: the development of the protocol. Prev Med. 1981;10:402-425.
7. Neaton JD, Grimm RH Jr, Cutler JA. Recruitment of participants for the Multiple Risk Factor Intervention Trial (MRFIT). Controlled Clin Trials. 1987;8:41S-53S.
8. Benfari RC. Multiple Risk Factor Intervention Trial (MRFIT), III: the model for intervention. Prev Med. 1981;10:426-442.
9. Caggiula AW, Christakis G, Farrand M, Hulley SB, Johnson R, Lasser NL, Stamler J, Widdowson G. Multiple Risk Factor Intervention Trial (MRFIT), IV: intervention on blood lipids. Prev Med. 1981;10:443-475.
10. Hughes GH, Hymowitz N, Ockene JK, Simon N, Vogt TM, Multiple Risk Factor Intervention Trial (MRFIT), V: intervention on smoking. Prev Med. 1981;10:476-500.
11. Cohen JD, Grimm RH, Smith WM. Multiple Risk Factor Intervention Trial (MRFIT), VI: intervention on blood pressure. Prev Med. 1981;10:501-518.
12. Wentworth D, Neaton J, Rasmussen W. An evaluation of the Social Security Administration Master Beneficiary Record File and the National Death Index in the ascertainment of vital status. Am J Public Health. 1983;73:1270-1274.
13. International Classification of Diseases, North American Clinical Modification. Ann Arbor, Mich: Edwards; 1981;1.
14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemoth Rep. 1966;50:163-170.
15. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-220.
16. Cutler JA, Grandits GA, Grimm RH Jr, Thomas HE Jr, Billings JH, Wright NH. Risk factor changes after cessation of intervention in the Multiple Risk Factor Intervention Trial: the MRFIT Research Group. Prev Med. 1991;20:183-196.
17. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease: overall findings and differences by age for 316,099 white men. Arch Intern Med. 1992;152:56-64.
18. Haheim LL, Holme I, Hjermann I, Leren P. The predictability of risk factors with respect to incidence and mortality of myocardial infarction and total mortality: a 12-year follow-up of the Oslo Study, Norway. J Intern Med. 1993;234:17-24.
19. Selmer R. Blood pressure and twenty-year mortality in the city of Bergen, Norway. Am J Epidemiol. 1992;136:428-440.
20. Pekkanen J, Nissinen A, Punsar S, Karvnen MJ. Short- and long-term association of serum cholesterol with mortality: the 25-year follow-up of the Finnish cohorts of the seven countries study. Am J Epidemiol. 1992;135:1251-1258.
21. White AD, Hames CG, Tyroler HA. Serum cholesterol and 20-year mortality in black and white men and women aged 65 and older in the Evans County Heart Study. Ann Epidemiol. 1992;2:85-91,
22. Higgins M, Keller JB. Cholesterol, coronary heart disease, and total mortality in middle-aged and elderly men and women in Tecumseh. Ann Epidemiol. 1992;2:69-76.
23. Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, Hunter DJ, Hennekins CH, Speizer FE. Smoking cessation in relation to total mortality rates in women: a prospective cohort study. Ann Intern Med. 1993;119:992-1000.
24. Holme I, Hjermann I, Hegleland A, Leren P. The Oslo Study: diet and antismoking advice: additional results from a 5-year primary preventive trial in middle-aged men. Prev Med. 1985;14:279-292.
25. Hjermann I. Non-pharmacological prevention of coronary heart disease. Presented at the 61st Meeting of the European Atherosclerosis Society; May 18, 1993; Capri, Italy.
26. Strandberg TE, Salomaa VV, Naukkarinen VA, Vanhanen HT, Sarna SJ, Miettinen TA. Long-term mortality after 5-years multifactorial primary prevention of cardiovascular diseases in middle-aged men. JAMA. 1991;266:1225-1229.
27. Strandberg TE, Salomaa W, Naukkarinen VA, Vanhanen HT, Sarna SJ, Miettinen TA. Cardiovascular morbidity and multifactorial primary prevention: fifteen-year follow-up of the Helsinki Businessmen Study. Nutr Metab Cardiovasc Dis. 1995;5:7-15.
28. Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K, Vedin A, Wilhelmsson C, Werkö L. The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J. 1986;7:279-288.
29. De Backer G, Kornitzer M, Dramaix M, Kittel F, Thilly C, Graffar M, Vuylsteek K. The Belgian Heart Disease Prevention Project: 10-year mortality follow-up. Eur Heart J. 1988;9:238-242.
30. Stamler J. Lessons from the Helsinki Multifactorial Primary Prevention Trial. Nutr Metab Cardiovasc Dis. 1995;5:1-5. Editorial.